In vitro and in vivo evaluations of sodium lauryl sulfate and dextran sulfate as microbicides against herpes simplex and human immunodeficiency viruses

Journal of Clinical Microbiology

Volumn 38, Issue 1, 2000, Pages 110-119

  Piret, Jocelyne ^a   Lamontagne, Julie ^a   Bestman Smith, Julie ^a   Roy, Sylvie ^a   Gourde, Pierrette ^a   Désormeaux, André ^a   Omar, Rabeea F ^a   Juhász, Julianna ^b   Bergeron, Michel G ^a,c  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN SULFATE; DODECYL SULFATE SODIUM;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; DRUG EFFECT; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; SEXUAL TRANSMISSION; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANIMALS; ANTIVIRAL AGENTS; CERCOPITHECUS AETHIOPS; DEXTRAN SULFATE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENES, VIRAL; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HIV-1; MICE; MICE, INBRED HRS; PLAQUE ASSAY; SEXUALLY TRANSMITTED DISEASES; SIMPLEXVIRUS; SODIUM DODECYL SULFATE; VAGINAL DISEASES; VERO CELLS; VIRAL ENVELOPE PROTEINS; VIRUS REPLICATION;

EID: 0033988128     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Alexander, N. J. 1995. Future contraceptives. Sci. Am. 273:136-141.
2. Baba, M., R. Pauwels, J. Balzarini, J. Arnout, and E. De Clercq. 1988. Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro. Proc. Natl. Acad. Sci. USA 85: 6132-6136.
3. Baba, M., D. Schols, E. De Clercq, R. Pauwels, M. Nagy, J. Gyorgyi-Edelenyi, M. Low, and G. Sandor. 1990. Novel sulfated polymers as highly potent and selective inhibitors of human immunodeficiency virus replication and giant cell formation. Antimicrob. Agents Chemother. 34:134-138.
4. Baba, M., R. Snoeck, R. Pauwels, and E. De Clercq. 1988. Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus. Antimicrob. Agents Chemother. 32: 1742-1745.
5. Batinic, D., and F. A. Robey. 1992. The V3 region of the envelope glycoprotein of human immunodeficiency virus type 1 binds sulfated polysaccharides and CD4-derived synthetic peptides. J. Biol. Chem. 267:6664-6671.
6. Bérubé, P., B. Barbeau, R. Cantin, R. P. Sékaly, and M. Tremblay. 1996. Repression of human immunodeficiency virus type 1 LTR-driven gene expression by the binding of the virus to its primary cellular receptor, the CD4 molecule. J. Virol. 70:4009-4016.
7. Bourinbaiar, A. S., and S. Lee-Huang. 1994. Comparative in vitro study of contraceptive agents with anti-HIV activity: gramicidin, nonoxynol-9 and gossypol. Contraception 49:131-137.
8. Burton, K. 1968. Methods in enzymology, p. 163-166. In L. Grosmann and K. Moldave (ed.), vol. 12. Academic Press, New York, N.Y.
9. Buttke, T. M., J. A. McCubrey, and T. C. Owen. 1993. Use of an aqueous soluble tetrazolium/formazan assay to measure viability and proliferation of lymphocyte-dependent cell lines. J. Immun. Methods 157:223-240.
10. Chen, C., and H. Okayama. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2745-2752.
11. Désormeaux, A., R. F. Omar, and M. G. Bergeron. 1999. Topical microbicides for the prevention of STDs/HIV. Can. J. Infect. Dis. 10(Suppl. C):41C-48C.
12. du Guerny, J., and E. Sjoberg. 1993. Inter-relationship between gender relations and the HIV/AIDS epidemic: some possible considerations for policies and programmes. AIDS 7:1027.
13. Eng, T. R., and W. T. Butler (ed.). 1997. The hidden epidemic: confronting sexually transmitted diseases. National Academy Press, Washington, D.C.
14. Feldblum, P. J., and S. S. Weir. 1994. The protective effect of nonoxynol-9 against HIV infection. Am. J. Public Health 84:1032-1034.
15. Fortin, J.-F., R. Cantin, G. Lamontagne, and M. Tremblay. 1997. Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity. J. Virol. 71:3588-3596.
16. Gagné, N., H. Cormier, R. F. Omar, A. Désormeaux, P. Gourde, M. J. Tremblay, J. Juhász, D. Beauchamp, J. E. Rioux, and M. G. Bergeron. 1999. Protective effect of a thermoreversible gel against the toxicity of nonoxynol-9. Sex. Transm. Dis. 26:177-183.
17. Gerbase, A. T., J. T. Rowley, and T. E. Mertens. 1998. Global epidemiology of sexually transmitted diseases. Lancet 351(Suppl. III):2-4.
18. Gibson, W., and B. Roizman. 1972. Proteins specified by herpes simplex virus: VIII. Characterization and composition of multiple capsid forms of subtypes 1 and 2. J. Virol. 10:1044-1052.
19. Herold, B. C., A. Siston, J. Bremer, R. Kirkpatrick, G. Wilbanks, P. Fugedi, C. Peto, and M. Cooper. 1997. Sulfated carbohydrate compounds prevent microbial adherence by sexually transmitted disease pathogens. Antimicrob. Agents Chemother. 41:2776-2780.
20. Howett, M. K., E. B. Neely, N. D. Christensen, B. Wigdahl, F. C. Krebs, D. Malamud, S. D. Patrick, M. D. Pickel, P. A. Welsh, C. A. Reed, M. G. Ward, L. R. Budgeon, and J. W. Kreider. 1999. A broad-spectrum microbicide with virucidal activity against sexually transmitted viruses. Antimicrob. Agents Chemother. 43:314-321.
21. Ito, M., M. Baba, A. Sato, R. Pauwels, E. De Clercq, and S. Shigeta. 1987. Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro. Antivir. Res. 7:361-367.
22. Jennings, R., and A. Clegg. 1993. The inhibitory effect of spermicidal agents on replication of HSV-2 and HIV-1 in vitro. J. Antimicrob. Chemother. 32:71-82.
23. Kreiss, J., E. Ngugi, K. Holmes, J. Ndinya-Achola, P. Waiyaki, P. L. Roberts, I. Ruminjo, R. Sajabi, J. Kimata, T. R. Fleming, A. Anzala, D. Holton, and F. Plummer. 1992. Efficacy of nonoxynol-9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. JAMA 268:477-482.
24. Lobe, D. C., T. Spector, and N. Ellis. 1991. Synergistic topical therapy by acyclovir and A1110U for herpes simplex virus induced zosteriform rash in mice. Antivir. Res. 15:87-100.
25. Lucin, P., S. Jonjic, M. Messerle, B. Polic, and H. Hengle. 1994. Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumour necrosis factor. J. Gen. Virol. 75:101-110.
26. + cells. Science 226:172-174.
27. Neyts, J., and E. De Clercq. 1995. Effect of polyanionic compounds on intracutaneous and intravaginal herpesvirus infection in mice: impact on the search for vaginal microbicides with anti-HIV activity. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 10:8-12.
28. Neyts, J., R. Snoeck, D. Schols, J. Balzarini, J. D. Esko, A. V. Schepdael, and E. De Clercq. 1992. Sulfated polymers inhibit the interaction of human cytomegalovirus with cell surface heparan sulfate. Virology 189:48-58.
29. Perdue, M. L., J. C. Cohen, M. C. Kemp, C. C. Randall, and D. J. O'Callaghan. 1975. Characterization of three species of nucleocapsid of equine herpesvirus type-1 (EHV-1). Virology 64:187-204.
30. Perdue, M. L., J. C. Cohen, C. C. Randall, and D. J. O'Callaghan. 1976. Biochemical studies of the maturation of herpes virus nucleocapsid species. Virology 74:194-208.
31. Perdue, M. L., M. C. Kemp, C. C. Randall, and D. J. O'Callaghan. 1974. Studies of the molecular anatomy of the L-M strain of equine herpes virus type 1: proteins of the nucleocapsid and intact virion. Virology 59:201-216.
32. Preston, V. G., F. J. Rixon, I. M. McDougall, M. McGragor, and M. F. Al-Kobaisi. 1992. Processing of herpes simplex virus assembly protein ICP35 near its carboxy terminal end requires the product of the whole of the UL26 reading frame. Virology 186:87-93.
33. Roddy, R. E., L. Zekeng, K. A. Ryan, U. Tamoufé, S. S. Weir, and E. L. Wong. 1998. A controlled trial of nonoxynol-9 film to reduce male-to-female transmission of sexually transmitted diseases. N. Engl. J. Med. 339:504-510.
34. Rosenthal, S. L., S. S. Cohen, and L. R. Stanberry. 1998. Topical microbicides. Current status and research considerations for adolescent girls. Sex. Transm. Dis. 25:368-377.
35. Rostand, K. S., and J. D. Esko. 1997. Microbial adherence to and invasion through proteoglycans. Infect. Immun. 65:1-8.
36. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
37. Sherman, G., and S. L. Bachenheimer. 1988. Characterization of intranuclear capsids made by ts morphogenic mutants of HSV-1. Virology 163:471-480.
38. Stafford, M. K., H. Ward, A. Flanagan, I. J. Rosenstein, D. Taylor-Robinson, J. R. Smith, J. Weber, and V. S. Kitchen. 1998. Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 17:327-331.
39. Ward, R. L., and C. S. Ashley. 1980. Comparative study on the mechanisms of rotavirus inactivation by sodium dodecyl sulfate and ethylediaminetetraacetate. Appl. Environ. Microbiol. 39:1148-1153.
40. Ward, R. L., and C. S. Ashley. 1979. pH modification of the effects of detergents on the stability of enteric viruses. Appl. Environ. Microbiol. 38:314-322.
41. Weir, S. S., P. J. Feldblum, L. Zekeng, and R. E. Roddy. 1994. The use of nonoxynol-9 for protection against cervical gonorrhea. Am. J. Public Health 84:910-914.
42. Zekeng, L., P. J. Feldblum, R. M. Oliver, and L. Kaptue. 1993. Barrier contraceptive use and HIV infection among high-risk women in Cameroon. AIDS 7:725-731.